ADMA Biologics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 11.41 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.56B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Details
| Name | ADMA Biologics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 647 |
| Founded | 2004 |
| Ceo | Adam Grossman |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US0008991046 |
| Cusip | 000899104 |
| Cik | 0001368514 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Adam S. Grossman | Co-Founder, President, Chief Executive Officer and Director |
| Dr. Jerrold B. Grossman D.P.S., Ph.D. | Co-Founder and Vice Chairman of the Board |
| P. Terence Kohler | Chief Financial Officer and Treasurer |
| Kaitlin M. Kestenberg | Chief Operating Officer and Senior Vice President of Compliance |
| Michael Goldstein | General Counsel |
| John Hafl | Executive Director of Sales |
| Skyler Bloom | Senior Director of Business Development and Corporate Strategy |
Contact
| Address | 465 State Route 17, Ramsey, New Jersey 07446, United States |
| Phone | 201 478 5552 |
| Website | https://www.admabiologics.com |